PMC6404238_01
Chest radiograph reveals the Impella 2.5 device positioned into the left
ventricle.
10.1177_2050313X19834816-fig1.jpg
PMC6404238_01_10.1177_2050313X19834816-fig1.jpg
fig1-2050313X19834816
Due to severe cardiogenic shock, an Impella 2.5 device (ABIOMED Inc., Danvers, MA, USA) was deployed through the femoral artery (Figure 1).
Chest radiograph reveals the central cannulation for the VA ECMO support.
10.1177_2050313X19834816-fig2.jpg
PMC6404238_01_10.1177_2050313X19834816-fig2.jpg
fig2-2050313X19834816
ECMO support was established via central cannulation and left ventricle (LV) vent was placed through the right superior pulmonary vein and connected to the inflow cannula in a Y-shaped fashion to unload the LV. ECMO support was continued for 15 days during which the circuit was changed once due to thrombus formation in the circuit (Figure 2).
Chest radiograph reveals the HVAD implanted into the apex of the left
ventricle.
10.1177_2050313X19834816-fig3.jpg
PMC6404238_01_10.1177_2050313X19834816-fig3.jpg
fig3-2050313X19834816
After 15 days of ECMO support, a HVAD (Medtronic, Minneapolis, MN, USA) was implanted and ECMO was discontinued (Figure 3).